{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T01:04:18Z","timestamp":1791594258181,"version":"4.3.4"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,4,23]],"date-time":"2018-04-23T00:00:00Z","timestamp":1524441600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000005","name":"US Department of Defense, Defense Centers of Excellence for Psychological Health and Traumatic Brain Injury","doi-asserted-by":"publisher","award":["HQ0034-16-D-0001"],"award-info":[{"award-number":["HQ0034-16-D-0001"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.jsat.2018.03.001","type":"journal-article","created":{"date-parts":[[2018,3,18]],"date-time":"2018-03-18T19:32:00Z","timestamp":1521401520000},"page":"28-51","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"special_numbering":"C","title":["Effects of medication assisted treatment (MAT) for opioid use disorder on functional outcomes: A systematic review"],"prefix":"10.1016","volume":"89","author":[{"given":"Margaret A.","family":"Maglione","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Raaen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulrez","family":"Azhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nima","family":"Shahidinia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mimi","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1945-3061","authenticated-orcid":false,"given":"Ervant","family":"Maksabedian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta M.","family":"Shanman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sydne","family":"Newberry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1597-5110","authenticated-orcid":false,"given":"Susanne","family":"Hempel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jsat.2018.03.001_bb0005","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3109\/08039488.2010.531762","article-title":"Effectiveness of buprenorphine maintenance treatment as compared to a syringe exchange program among buprenorphine misusing opioid-dependent patients","volume":"65","author":"Aalto","year":"2011","journal-title":"Nordic Journal of Psychiatry"},{"key":"10.1016\/j.jsat.2018.03.001_bb0010","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.neubiorev.2016.11.008","article-title":"Neuropsychological functioning and chronic methadone use: A systematic review and meta-analysis","volume":"73","author":"Baldacchino","year":"2017","journal-title":"Neuroscience and Biobehavioral Reviews"},{"issue":"2","key":"10.1016\/j.jsat.2018.03.001_bb0015","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/archpsyc.1980.01780150069008","article-title":"Therapeutic communities vs methadone maintenance: A prospective controlled study of narcotic addiction treatment-design and one-year follow-up","volume":"37","author":"Bale","year":"1980","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jsat.2018.03.001_bb0020","series-title":"The effectiveness of methadone maintenance treatment: Patients, programs, services, and outcome","author":"Ball","year":"1991"},{"issue":"4","key":"10.1016\/j.jsat.2018.03.001_bb0025","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1016\/j.jsat.2018.03.001_bb0030","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.neubiorev.2016.09.011","article-title":"Decision-making ability in current and past users of opiates: A meta-analysis","volume":"71","author":"Biernacki","year":"2016","journal-title":"Neuroscience and Biobehavioral Reviews"},{"issue":"5","key":"10.1016\/j.jsat.2018.03.001_bb0035","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1192\/bjp.bp.112.111583","article-title":"Cost-effectiveness of injectable opioid treatment v. oral methadone for chronic heroin addiction","volume":"203","author":"Byford","year":"2013","journal-title":"The British Journal of Psychiatry"},{"key":"10.1016\/j.jsat.2018.03.001_bb0040","author":"Center for Substance Abuse Treatment Division of Pharmacologic Therapies"},{"key":"10.1016\/j.jsat.2018.03.001_bb0045","first-page":"1","article-title":"Increases in drug and opioid overdose deaths \u2014 United States, 2000\u20132014","volume":"64","author":"Centers for Disease Control and Prevention","year":"2015","journal-title":"Morbidity and Mortality Weekly Report (MMWR)"},{"key":"10.1016\/j.jsat.2018.03.001_bb0050","series-title":"Statistical power analysis for the behavioral sciences","author":"Cohen","year":"1988"},{"issue":"4","key":"10.1016\/j.jsat.2018.03.001_bb0055","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jpain.2012.01.001","article-title":"Hyperalgesia in heroin dependent patients and the effects of opioid substitution therapy","volume":"13","author":"Compton","year":"2012","journal-title":"The Journal of Pain"},{"issue":"6","key":"10.1016\/j.jsat.2018.03.001_bb0060","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0740-5472(97)00020-2","article-title":"Naltrexone pharmacotherapy for opioid dependent federal probationers","volume":"14","author":"Cornish","year":"1997","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1\u20133","key":"10.1016\/j.jsat.2018.03.001_bb0065","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.drugalcdep.2011.10.022","article-title":"Road traffic crashes and prescribed methadone and buprenorphine: A French registry-based case-control study","volume":"123","author":"Corsenac","year":"2012","journal-title":"Drug and Alcohol Dependence"},{"issue":"5","key":"10.1016\/j.jsat.2018.03.001_bb0070","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1521-0391.2010.00070.x","article-title":"A randomized trial of oral naltrexone for treating opioid-dependent offenders","volume":"19","author":"Coviello","year":"2010","journal-title":"The American Journal on Addictions"},{"issue":"2","key":"10.1016\/j.jsat.2018.03.001_bb0075","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jsat.2010.09.007","article-title":"Characteristics and 9-month outcomes of discharged methadone maintenance clients","volume":"40","author":"Coviello","year":"2011","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2018.03.001_bb0080","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jsat.2015.03.003","article-title":"Extended-release naltrexone for alcohol and opioid problems in Missouri parolees and probationers","volume":"56","author":"Crits-Christoph","year":"2015","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"25","key":"10.1016\/j.jsat.2018.03.001_bb0085","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1056\/NEJM196906192802502","article-title":"Methadone treatment of randomly selected criminal addicts","volume":"280","author":"Dole","year":"1969","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.jsat.2018.03.001_bb0090","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.drugalcdep.2017.01.016","article-title":"Effectiveness and cost-effectiveness of unsupervised buprenorphine-naloxone for the treatment of heroin dependence in a randomized waitlist controlled trial","volume":"174","author":"Dunlop","year":"2017","journal-title":"Drug and Alcohol Dependence"},{"issue":"7109","key":"10.1016\/j.jsat.2018.03.001_bb0095","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"British Medical Journal"},{"issue":"4","key":"10.1016\/j.jsat.2018.03.001_bb0100","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1159\/000357942","article-title":"Impact of methadone maintenance treatment on women offenders' post-release recidivism","volume":"20","author":"Farrell-MacDonald","year":"2014","journal-title":"European Addiction Research"},{"issue":"10","key":"10.1016\/j.jsat.2018.03.001_bb0105","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1056\/NEJMoa022164","article-title":"Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone","volume":"349","author":"Fudala","year":"2003","journal-title":"The New England Journal of Medicine"},{"issue":"2","key":"10.1016\/j.jsat.2018.03.001_bb0110","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1176\/appi.ps.201300235","article-title":"Medication-assisted treatment with methadone: Assessing the evidence","volume":"65","author":"Fullerton","year":"2014","journal-title":"Psychiatric Services"},{"issue":"1\u20133","key":"10.1016\/j.jsat.2018.03.001_bb0115","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.psychres.2006.02.013","article-title":"Experimentally induced aggressiveness in heroin-dependent patients treated with buprenorphine: Comparison of patients receiving methadone and healthy subjects","volume":"149","author":"Gerra","year":"2007","journal-title":"Psychiatry Research"},{"issue":"2","key":"10.1016\/j.jsat.2018.03.001_bb0120","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1080\/10826080500391845","article-title":"Opioid addicts at admission vs. slow-release oral morphine, methadone, and sublingual buprenorphine maintenance treatment participants","volume":"41","author":"Giacomuzzi","year":"2006","journal-title":"Substance Use & Misuse"},{"key":"10.1016\/j.jsat.2018.03.001_bb0125","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1100\/tsw.2005.52","article-title":"Sublingual buprenorphine and methadone maintenance treatment: A three-year follow-up of quality of life assessment","volume":"5","author":"Giacomuzzi","year":"2005","journal-title":"The Scientific World Journal"},{"issue":"5","key":"10.1016\/j.jsat.2018.03.001_bb0130","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1046\/j.1360-0443.2003.00352.x","article-title":"Buprenorphine versus methadone maintenance treatment in an ambulant setting: A health-related quality of life assessment","volume":"98","author":"Giacomuzzi","year":"2003","journal-title":"Addiction"},{"issue":"8","key":"10.1016\/j.jsat.2018.03.001_bb0135","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/j.1360-0443.2008.002238.x","article-title":"A randomized clinical trial of methadone maintenance for prisoners: Findings at 6months post-release","volume":"103","author":"Gordon","year":"2008","journal-title":"Addiction"},{"issue":"438","key":"10.1016\/j.jsat.2018.03.001_bb0140","first-page":"31","article-title":"Methadone treatment practices and outcome for opiate addicts treated in drug clinics and in general practice: Results from the National Treatment Outcome Research Study","volume":"49","author":"Gossop","year":"1999","journal-title":"British Journal of General Practice"},{"issue":"8","key":"10.1016\/j.jsat.2018.03.001_bb0145","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1002\/(SICI)1521-4036(199912)41:8<901::AID-BIMJ901>3.0.CO;2-W","article-title":"An alternative method for meta-analysis","volume":"41","author":"Hartung","year":"1999","journal-title":"Biometrical Journal"},{"issue":"24","key":"10.1016\/j.jsat.2018.03.001_bb0150","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1002\/sim.1009","article-title":"A refined method for the meta-analysis of controlled clinical trials with binary outcome","volume":"20","author":"Hartung","year":"2001","journal-title":"Statistics in Medicine"},{"key":"10.1016\/j.jsat.2018.03.001_bb0155","series-title":"Cochrane handbook for systematic reviews of interventions version 5.1.0","author":"Higgins","year":"2011"},{"issue":"7414","key":"10.1016\/j.jsat.2018.03.001_bb0160","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"issue":"25","key":"10.1016\/j.jsat.2018.03.001_bb0165","first-page":"1","article-title":"The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method","volume":"14","author":"IntHout","year":"2014","journal-title":"BMC Medical Research Methodology"},{"issue":"1\u20132","key":"10.1016\/j.jsat.2018.03.001_bb0170","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.drugalcdep.2013.01.007","article-title":"Heroin use and heroin use risk behaviors among nonmedical users of prescription opioid pain relievers - United States, 2002\u20132004 and 2008\u20132010","volume":"132","author":"Jones","year":"2013","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"10.1016\/j.jsat.2018.03.001_bb0175","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jsat.2009.03.002","article-title":"A randomized clinical trial of methadone maintenance for prisoners: Results at 12months postrelease","volume":"37","author":"Kinlock","year":"2009","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"4","key":"10.1016\/j.jsat.2018.03.001_bb0180","doi-asserted-by":"crossref","first-page":"419","DOI":"10.4155\/tde.15.3","article-title":"Buprenorphine: Revisiting the efficacy of transdermal delivery system","volume":"6","author":"Kitzmiller","year":"2015","journal-title":"Therapeutic Delivery"},{"key":"10.1016\/j.jsat.2018.03.001_bb0185","first-page":"e125","article-title":"Extended-release naltrexone for opioid relapse prevention among opioid-dependent, criminal justice-involved adults","volume":"156","author":"Lee","year":"2015","journal-title":"Drug and Alcohol Dependence"},{"issue":"13","key":"10.1016\/j.jsat.2018.03.001_bb0190","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1056\/NEJMoa1505409","article-title":"Extended-release naltrexone to prevent opioid relapse in criminal justice offenders","volume":"374","author":"Lee","year":"2016","journal-title":"New England Journal of Medicine"},{"issue":"14","key":"10.1016\/j.jsat.2018.03.001_bb0195","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1001\/jama.2010.1427","article-title":"Buprenorphine implants for treatment of opioid dependence: A randomized controlled trial","volume":"304","author":"Ling","year":"2010","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.jsat.2018.03.001_bb0200","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000313336","article-title":"Naltrexone implants compared to methadone: Outcomes six months after prison release","volume":"16","author":"Lobmaier","year":"2010","journal-title":"European Addiction Research"},{"issue":"1\u20133","key":"10.1016\/j.jsat.2018.03.001_bb0205","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.drugalcdep.2008.08.006","article-title":"Buprenorphine and methadone maintenance in jail and post-release: A randomized clinical trial","volume":"99","author":"Magura","year":"2009","journal-title":"Drug and Alcohol Dependence"},{"issue":"4","key":"10.1016\/j.jsat.2018.03.001_bb0210","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1046\/j.1360-0443.2003.00335.x","article-title":"Buprenorphine versus methadone maintenance therapy: A randomized double-blind trial with 405 opioid-dependent patients","volume":"98","author":"Mattick","year":"2003","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2018.03.001_bb0215","first-page":"Cd002209","article-title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence","volume":"3","author":"Mattick","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.jsat.2018.03.001_bb9000","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/add.12748","article-title":"Drug use, health and social outcomes of hard-to-treat heroin addicts receiving supervised injectable opiate treatment: Secondary outcomes from the randomized injectable opioid treatment trial (RIOTT)","volume":"110","author":"Metrebian","year":"2015","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2018.03.001_bb0220","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1111\/add.13259","article-title":"Medical treatments for opioid use disorder in Iran: A randomized, double-blind placebo-controlled comparison of buprenorphine\/naloxone and naltrexone maintenance treatment","volume":"5","author":"Mokri","year":"2016","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2018.03.001_bb0225","doi-asserted-by":"crossref","DOI":"10.1111\/add.13807","article-title":"Cost-effectiveness of extended release naltrexone to prevent relapse among criminal justice-involved individuals with a history of opioid use disorder","author":"Murphy","year":"2017","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2018.03.001_bb0230","author":"National Institute on Drug Abuse"},{"issue":"3","key":"10.1016\/j.jsat.2018.03.001_bb0235","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1007\/s00213-005-2239-x","article-title":"Randomized clinical trial to compare the effects of methadone and buprenorphine on the immune system in drug abusers","volume":"179","author":"Neri","year":"2005","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.jsat.2018.03.001_bb0240","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1080\/10550887.2012.759872","article-title":"A preliminary study comparing methadone and buprenorphine in patients with chronic pain and coexistent opioid addiction","volume":"32","author":"Neumann","year":"2013","journal-title":"Journal of Addictive Diseases"},{"issue":"8141","key":"10.1016\/j.jsat.2018.03.001_bb0245","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0140-6736(79)91550-2","article-title":"Double-blind comparison of methadone and placebo maintenance treatments of narcotic addicts in Hong Kong","volume":"2","author":"Newman","year":"1979","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.jsat.2018.03.001_bb0250","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1093\/ije\/dyn065","article-title":"Sensitivity of between-study heterogeneity in meta-analysis: Proposed metrics and empirical evaluation","volume":"37","author":"Patsopoulos","year":"2008","journal-title":"International Journal of Epidemiology"},{"key":"10.1016\/j.jsat.2018.03.001_bb0255","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1747-597X-4-6","article-title":"Memory function in opioid-dependent patients treated with methadone or buprenorphine along with benzodiazepine: Longitudinal change in comparison to healthy individuals","volume":"4","author":"Rapeli","year":"2009","journal-title":"Substance Abuse Treatment, Prevention, and Policy"},{"key":"10.1016\/j.jsat.2018.03.001_bb0260","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1472-6904-11-13","article-title":"Cognitive functioning in opioid-dependent patients treated with buprenorphine, methadone, and other psychoactive medications: Stability and correlates","volume":"11","author":"Rapeli","year":"2011","journal-title":"BMC Clinical Pharmacology"},{"issue":"1","key":"10.1016\/j.jsat.2018.03.001_bb0265","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3109\/10826089309038922","article-title":"Methadone maintenance clients in Amsterdam after five years","volume":"28","author":"Reijneveld","year":"1993","journal-title":"The International Journal of the Addictions"},{"issue":"12","key":"10.1016\/j.jsat.2018.03.001_bb0270","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1111\/add.12315","article-title":"Buprenorphine implants for treatment of opioid dependence: Randomized comparison to placebo and sublingual buprenorphine\/naloxone","volume":"108","author":"Rosenthal","year":"2013","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.jsat.2018.03.001_bb0275","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1001\/jama.2016.9382","article-title":"Effect of buprenorphine implants on illicit opioid use among abstinent adults with opioid dependence treated with sublingual buprenorphine: A randomized clinical trial","volume":"316","author":"Rosenthal","year":"2016","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.jsat.2018.03.001_bb0280","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00038-008-7068-3","article-title":"When to use the odds ratio or the relative risk?","volume":"53","author":"Schmidt","year":"2008","journal-title":"International Journal of Public Health"},{"issue":"1","key":"10.1016\/j.jsat.2018.03.001_bb0285","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.drugalcdep.2006.04.017","article-title":"A randomized controlled trial of interim methadone maintenance: 10-month follow-up","volume":"86","author":"Schwartz","year":"2007","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"10.1016\/j.jsat.2018.03.001_bb0290","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.drugalcdep.2009.03.007","article-title":"Interim methadone treatment: Impact on arrests","volume":"103","author":"Schwartz","year":"2009","journal-title":"Drug and Alcohol Dependence"},{"issue":"10","key":"10.1016\/j.jsat.2018.03.001_bb0295","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1001\/jama.283.10.1303","article-title":"Methadone maintenance versus 180-day psychosocially enriched detoxification for treatment of opioid dependence: A randomized controlled trial","volume":"283","author":"Sees","year":"2000","journal-title":"Journal of the American Medical Association"},{"issue":"4","key":"10.1016\/j.jsat.2018.03.001_bb0300","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1300\/J069v12n04_05","article-title":"Medical maintenance: a pilot study","volume":"12","author":"Senay","year":"1993","journal-title":"J Addict Dis"},{"issue":"12","key":"10.1016\/j.jsat.2018.03.001_bb0305","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1016\/j.csda.2005.07.019","article-title":"Robust variance estimation for random effects meta-analysis","volume":"50","author":"Sidik","year":"2006","journal-title":"Computational Statistics & Data Analysis"},{"issue":"5","key":"10.1016\/j.jsat.2018.03.001_bb0310","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/01.jcp.0000178417.60426.60","article-title":"Less impairment on one portion of a driving-relevant psychomotor battery in buprenorphine-maintained than in methadone-maintained patients: Results of a randomized clinical trial","volume":"25","author":"Soyka","year":"2005","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"6","key":"10.1016\/j.jsat.2018.03.001_bb0315","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/JCP.0b013e31818a6d38","article-title":"Cognitive functioning during methadone and buprenorphine treatment: Results of a randomized clinical trial","volume":"28","author":"Soyka","year":"2008","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"5","key":"10.1016\/j.jsat.2018.03.001_bb0320","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1017\/S146114570700836X","article-title":"Retention rate and substance use in methadone and buprenorphine maintenance therapy and predictors of outcome: Results from a randomized study","volume":"11","author":"Soyka","year":"2008","journal-title":"The International Journal of Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.jsat.2018.03.001_bb0325","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0376-8716(93)90052-R","article-title":"Methadone dose and treatment outcome","volume":"33","author":"Strain","year":"1993","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.jsat.2018.03.001_bb0330","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1080\/15389588.2012.689451","article-title":"Can patients receiving opioid maintenance therapy safely drive? A systematic review of epidemiological and experimental studies on driving ability with a focus on concomitant methadone or buprenorphine administration","volume":"14","author":"Strand","year":"2013","journal-title":"Traffic Injury Prevention"},{"issue":"11","key":"10.1016\/j.jsat.2018.03.001_bb0335","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1046\/j.1360-0443.2000.951116314.x","article-title":"Randomized trial of supervised injectable versus oral methadone maintenance: Report of feasibility and 6-month outcome","volume":"95","author":"Strang","year":"2000","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2018.03.001_bb0340","series-title":"Behavioral health trends in the United States: Results from the 2014 National Survey on Drug Use and Health. Retrieved from Rockville, MD","author":"Substance Abuse and Mental Health Services Administration, & Center for Behavioral Health Statistics and Quality","year":"2015"},{"issue":"5","key":"10.1016\/j.jsat.2018.03.001_bb0345","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1176\/appi.ajp.2011.11071121","article-title":"Naltrexone implant for the treatment of polydrug dependence: A randomized controlled trial","volume":"169","author":"Tiihonen","year":"2012","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/j.jsat.2018.03.001_bb0350","author":"U.S. Department of Health and Human Services"},{"issue":"3","key":"10.1016\/j.jsat.2018.03.001_bb0355","doi-asserted-by":"crossref","first-page":"220","DOI":"10.2174\/18744737112059990020","article-title":"Methadone maintenance treatment and cognitive function: A systematic review","volume":"6","author":"Wang","year":"2013","journal-title":"Current Drug Abuse Reviews"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547217304828?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547217304828?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:48:07Z","timestamp":1760039287000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547217304828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":72,"alternative-id":["S0740547217304828"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2018.03.001","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of medication assisted treatment (MAT) for opioid use disorder on functional outcomes: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2018.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}